| scholarly article | Q13442814 |
| P50 | author | Evangelos Triantafyllou | Q41615078 |
| P2093 | author name string | Lucia A Possamai | |
| Mark J W McPhail | |||
| Charalambos G Antoniades | |||
| Kevin J Woollard | |||
| P2860 | cites work | Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine | Q22306067 |
| Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice | Q43657691 | ||
| Bacteremia, acute physiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure | Q43892582 | ||
| Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse | Q43974826 | ||
| High-mobility group box 1 (HMGB1)-Toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: Interaction of γδ T cells with macrophages | Q44112151 | ||
| Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice | Q44249123 | ||
| Toward an improved definition of acute-on-chronic liver failure. | Q44557131 | ||
| Infection and the progression of hepatic encephalopathy in acute liver failure | Q44569532 | ||
| Acetaminophen toxicity in mice lacking NADPH oxidase activity: role of peroxynitrite formation and mitochondrial oxidant stress | Q44749857 | ||
| The systemic inflammatory response syndrome in acute liver failure | Q45243727 | ||
| Circulating histones exacerbate inflammation in mice with acute liver failure | Q45359126 | ||
| Predictors of bacteraemia and mortality in patients with acute liver failure. | Q46063085 | ||
| Infiltrating monocyte-derived macrophages and resident kupffer cells display different ontogeny and functions in acute liver injury. | Q48281671 | ||
| Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage. | Q49644344 | ||
| Hepatocyte-specific deletion of IL1-RI attenuatesliver injury by blocking IL-1 driven autoinflammation. | Q49792253 | ||
| Infections complicating cirrhosis. | Q50087659 | ||
| Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles. | Q50223846 | ||
| Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury. | Q51702513 | ||
| Bacterial endotoxin induces the release of high mobility group box 1 via the IFN-beta signaling pathway. | Q51833198 | ||
| MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure. | Q52774474 | ||
| Plasma cholesteryl ester transfer protein is predominantly derived from Kupffer cells. | Q52931087 | ||
| Liver inflammation abrogates immunological tolerance induced by Kupffer cells. | Q52956130 | ||
| Spatiotemporal Characterization of the Cellular and Molecular Contributors to Liver Fibrosis in a Murine Hepatotoxic-Injury Model. | Q53211065 | ||
| Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. | Q53763296 | ||
| Acute Liver Failure | Q56069625 | ||
| Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis | Q56925206 | ||
| Aetiology and prognostic factors in acute liver failure in India | Q59829991 | ||
| Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice | Q60321190 | ||
| Secretory leukocyte protease inhibitor: A pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure | Q60713404 | ||
| Could targeting secretory leukocyte protease inhibitor be an effective therapeutic option to prevent infections in acute liver failure? | Q60713406 | ||
| Hepatic recruitment of the inflammatory Gr1+monocyte subset upon liver injury promotes hepatic fibrosis | Q62735118 | ||
| Granulocyte colony-stimulating factor improves function of neutrophils from patients with acute liver failure | Q73138416 | ||
| Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species | Q77933557 | ||
| Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure | Q79788203 | ||
| Patients with acute on chronic liver failure display "sepsis-like" immune paralysis | Q81305036 | ||
| Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis | Q81973058 | ||
| Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure | Q82692497 | ||
| Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis | Q82907563 | ||
| Admission levels and early changes in serum interleukin-10 are predictive of poor outcome in acute liver failure and decompensated cirrhosis | Q84195110 | ||
| Cyclophilin A is a damage-associated molecular pattern molecule that mediates acetaminophen-induced liver injury | Q84718475 | ||
| Lack of interleukin-1α in Kupffer cells attenuates liver inflammation and expression of inflammatory cytokines in hypercholesterolaemic mice | Q87383686 | ||
| What's new in acute liver failure? | Q88190258 | ||
| Exploring the full spectrum of macrophage activation | Q24653754 | ||
| The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) | Q26768286 | ||
| Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis | Q26851863 | ||
| Tissue-resident macrophages | Q26991488 | ||
| Natural killer cells in liver disease | Q27025451 | ||
| Toll like receptor 3 plays a critical role in the progression and severity of acetaminophen-induced hepatotoxicity | Q27316003 | ||
| Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis | Q27336127 | ||
| Infiltrating monocytes in liver injury and repair | Q28070341 | ||
| Macrophage plasticity and polarization: in vivo veritas | Q29547620 | ||
| A lineage of myeloid cells independent of Myb and hematopoietic stem cells | Q29620147 | ||
| Macrophage activation and polarization: nomenclature and experimental guidelines | Q29620642 | ||
| A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury. | Q30401463 | ||
| Ly6Chi Monocytes and Their Macrophage Descendants Regulate Neutrophil Function and Clearance in Acetaminophen-Induced Liver Injury | Q30854149 | ||
| Administering granulocyte colony-stimulating factor to acute liver failure patients corrects neutrophil defects | Q31976544 | ||
| The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis | Q33732343 | ||
| Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy | Q33828888 | ||
| The Impact of Sterile Inflammation in Acute Liver Injury | Q33847610 | ||
| Extracellular histones are major mediators of death in sepsis | Q34019901 | ||
| Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity | Q34024427 | ||
| Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans | Q34159110 | ||
| Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics | Q34326022 | ||
| Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure | Q34486321 | ||
| Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis | Q34646876 | ||
| Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. | Q34659689 | ||
| Macrophages: development and tissue specialization | Q34669239 | ||
| Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. | Q35623089 | ||
| P2X7 receptor-mediated purinergic signaling promotes liver injury in acetaminophen hepatotoxicity in mice | Q35994069 | ||
| Circulating cell death biomarker: good candidates of prognostic indicator for patients with hepatitis B virus related acute-on-chronic liver failure | Q36098872 | ||
| Soluble CD163 from activated macrophages predicts mortality in acute liver failure | Q36333669 | ||
| CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure | Q36353138 | ||
| Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis | Q36414956 | ||
| Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells | Q36534480 | ||
| Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failure | Q38524991 | ||
| Immunology in the liver--from homeostasis to disease | Q38693925 | ||
| Liver-resident macrophage necroptosis orchestrates type 1 microbicidal inflammation and type-2-mediated tissue repair during bacterial infection | Q38912390 | ||
| The Acute-on-Chronic Liver Failure Syndrome, or When the Innate Immune System Goes Astray | Q38999160 | ||
| Liver - guardian, modifier and target of sepsis | Q39031051 | ||
| Acute-on-chronic liver failure: an update. | Q39039989 | ||
| Targeting hepatic macrophages to treat liver diseases | Q39166232 | ||
| Liver macrophages in tissue homeostasis and disease | Q39187324 | ||
| Patients with HBV-related acute-on-chronic liver failure have increased concentrations of extracellular histones aggravating cellular damage and systemic inflammation | Q39359763 | ||
| Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure | Q39533703 | ||
| Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis | Q40077307 | ||
| A Liver Capsular Network of Monocyte-Derived Macrophages Restricts Hepatic Dissemination of Intraperitoneal Bacteria by Neutrophil Recruitment | Q40081249 | ||
| A Randomized, Placebo-Controlled Trial of Cenicriviroc for Treatment of Nonalcoholic Steatohepatitis with Fibrosis. | Q40082820 | ||
| CD14+CD15-HLA-DR- myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure. | Q40180993 | ||
| Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure | Q40270051 | ||
| Combination of Mass Cytometry and Imaging Analysis Reveals Origin, Location, and Functional Repopulation of Liver Myeloid Cells in Mice. | Q40480613 | ||
| A Reservoir of Mature Cavity Macrophages that Can Rapidly Invade Visceral Organs to Affect Tissue Repair. | Q40721153 | ||
| New insights into the multidimensional concept of macrophage ontogeny, activation and function. | Q40866271 | ||
| Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF). | Q41071756 | ||
| Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis | Q41443983 | ||
| A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug-induced liver injury and postinjury inflammation in mice | Q41593902 | ||
| Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK. | Q41615049 | ||
| Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases | Q41750314 | ||
| Blockade of high-mobility group box-1 ameliorates acute on chronic liver failure in rats. | Q42266454 | ||
| Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2. | Q42293558 | ||
| Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance | Q42382293 | ||
| CCR5 knockout mice with C57BL6 background are resistant to acetaminophen-mediated hepatotoxicity due to decreased macrophages migration into the liver | Q42705850 | ||
| High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo | Q43270651 | ||
| Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9 | Q36618530 | ||
| Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis | Q36625054 | ||
| Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity | Q36652448 | ||
| Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies | Q36870030 | ||
| Steroid use in acute liver failure | Q36939687 | ||
| Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury | Q37038993 | ||
| Identification and treatment of the Staphylococcus aureus reservoir in vivo | Q37047344 | ||
| Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure | Q37066630 | ||
| Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. | Q37073714 | ||
| Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice | Q37164206 | ||
| Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach | Q37233354 | ||
| Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functions | Q37266172 | ||
| The importance of immune dysfunction in determining outcome in acute liver failure | Q37272915 | ||
| Unsupervised High-Dimensional Analysis Aligns Dendritic Cells across Tissues and Species | Q37293474 | ||
| Circulating histones are major mediators of systemic inflammation and cellular injury in patients with acute liver failure | Q37330936 | ||
| Origins and tissue-context-dependent fates of blood monocytes | Q37338949 | ||
| Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital | Q37346819 | ||
| Role of hepatic resident and infiltrating macrophages in liver repair after acute injury. | Q37393413 | ||
| Endotoxin tolerance: new mechanisms, molecules and clinical significance | Q37603612 | ||
| Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure*. | Q37612383 | ||
| A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse | Q37649853 | ||
| IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology | Q38005217 | ||
| Sterile inflammation in the liver | Q38043897 | ||
| Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications. | Q38057416 | ||
| Immune surveillance by the liver | Q38139201 | ||
| Macrophage heterogeneity in liver injury and fibrosis | Q38177568 | ||
| Modulation of monocyte/macrophage function: a therapeutic strategy in the treatment of acute liver failure. | Q38202361 | ||
| Understanding infection susceptibility in patients with acute-on-chronic liver failure | Q38217984 | ||
| Origin and functions of tissue macrophages. | Q38230878 | ||
| Roles for chemokines in liver disease | Q38234487 | ||
| Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance | Q38241149 | ||
| Circulating neutrophil dysfunction in acute liver failure. | Q38320684 | ||
| Correlation between high mobility group box-1 protein and chronic hepatitis B infection with severe hepatitis B and acute-on-chronic liver failure: a meta-analysis | Q38374941 | ||
| Inflammasome activation and function in liver disease | Q38521274 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver failure | Q970208 |
| P304 | page(s) | 2948 | |
| P577 | publication date | 2018-12-14 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | The Role of Monocytes and Macrophages in Acute and Acute-on-Chronic Liver Failure | |
| P478 | volume | 9 |
| Q92996208 | A Benzenediamine Analog FC-99 Drives M2 Macrophage Polarization and Alleviates Lipopolysaccharide- (LPS-) Induced Liver Injury |
| Q92484959 | Acute kidney injury spectrum in patients with chronic liver disease: Where do we stand? |
| Q90205924 | Crosstalk network among multiple inflammatory mediators in liver fibrosis |
| Q100517651 | Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities |
| Q92307101 | Human amnion mesenchymal stem cells attenuate atherosclerosis by modulating macrophage function to reduce immune response |
| Q94503842 | Multispectral Imaging Enables Characterization of Intrahepatic Macrophages in Patients With Chronic Liver Disease |
| Q90697776 | Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis |
| Q89967090 | The Generation and Identity of Human Myeloid-Derived Suppressor Cells |
| Q64910522 | The Protective Effect of Magnesium Lithospermate B on Hepatic Ischemia/Reperfusion via Inhibiting the Jak2/Stat3 Signaling Pathway. |
| Q92072388 | Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases |
Search more.